Navigation Links
Henry Gabelnick receives lifetime achievement award
Date:5/27/2010

Arlington, VA (May 27, 2010) -- CONRAD is pleased to announce that Executive Director, Henry Gabelnick, Ph.D, was awarded the lifetime achievement award at the 6th International Microbicides 2010 Conference. This year's conference, Building Bridges to HIV Prevention, was held in Pittsburgh, Pennsylvania May 22-25 and before an audience of more than 1,000 HIV advocates and scientists, Dr. Gabelnick was recognized for his unparalleled commitment and dedication to the development of microbicides. The lifetime achievement award was his second in 2005, Dr. Gabelnick was recognized by the International Conference on AIDS India for a lifetime devoted to reproductive health.

"In a field with so many dedicated, brilliant and persistent researchers, I am tremendously honored to be singled out by my peers," said Dr. Gabelnick. His acceptance speech described his early years working in the chemical industry, specifically in the field of plastics, and his journey to more fulfilling work in the field of contraception and microbicides. Dr. Gabelnick received his undergraduate and graduate degrees at MIT and his doctorate from Princeton. After beginning his career in the chemical industry, Dr. Gabelnick moved to the Biomedical Engineering Branch of the National Institutes of Health. He joined CONRAD at its inception in 1986, and focused primarily on developing new methods of contraception until it became clear that HIV prevention was crucial to overall reproductive health. For the past 20 years, CONRAD has contributed to the microbicide development field through the development of preclinical algorithms and primate models, standardization of colposcopy techniques, biomarker research and clinical trials.

CONRAD scientists also presented the following study findings and analyses at various sessions during the conference:

  • Christine Mauck, M.D., M.P.H. - Assessing Markers of Inflammation after Vaginal Product Use: Nonoxynol-9, Cellulose Sulfate, and HEC Placebo Comparative Double-Blind Phase I Trial and Colposcopy: Still Useful in Microbicide Safety Trials?
  • Gustavo Doncel, M.D., Ph.D. - Combining HIV Prevention and Contraception Technologies
  • Mohammed Saifuddin, D.V.M., Ph.D. - Evaluation of 6% Cellulose Sulfate and 0.5% PRO2000 Gel Microbicide Efficacy in a Single-Dose Intravaginal R5+X4 SHIV Infection Model in Rhesus Macaques Pre-treated with Depo-Provera
  • Irina Zalenskaya, Ph.D. - Gene Expression Profile of Vaginal Epithelial Cells Exposed to Proinflammatory Agents - Identification of Novel Biomarkers of Mucosal Safety
  • Jill Schwartz, M.D. - Pilot Clinical Pharmacokinetic and Pharmacodynamic Study of UC781 Vaginal Gel


'/>"/>

Contact: Annette Larkin
larkinannette@yahoo.com
703-772-6427
CONRAD
Source:Eurekalert

Related medicine news :

1. Henry Ford Hospital study: Fewer infections with new heart-pump implant
2. Henry Ford Hospital: New left-side heart pump improves right-side heart function
3. Henry Ford Hospital study: Less prep needed for colonoscopy
4. Henry Ford Health System goes radical: Creating the hospital of the future
5. Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
6. Henry Ford Hospital study: Shoulder function not fully restored after surgery
7. Henry Ford Hospital study shows link between vitamin D, skin cancer
8. Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus
9. National Press Club to Host NEWSMAKER Media Briefing on Cornhusker Kickback With South Carolina Attorney General Henry McMaster
10. iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems
11. Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: